AZN vs PEN · P/E 28, $288.38B cap vs P/E 237, rev $764.8M
AstraZeneca PLC (AZN) versus Penumbra Inc (PEN) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Penumbra Inc (PEN) is a medical devices company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Not investment advice. Open the AZN and PEN stock pages for the full models.
Not investment advice.